VANI Stock Analysis: Buy, Sell, or Hold?
VANI - Vivani Medical, Inc. Common Stock (DE)
$1.17
-0.03 (-2.50%)
▼
5d:
-1.68%
30d:
-10.69%
90d:
-0.85%
BUY
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 18, 2026
0d
Smart Money Accumulation
VANI is down 8.8% this week, but smart money is accumulating calls. Top strike: $1 2026-06-18 with 1 OI. Call ratio: 100% View Scanner →
Strength: 9.4/10
Get Alerted When VANI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: VANI shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: VANI shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: VANI is currently trading at $1.17, which is considered slightly low relative to its 30-day fair value range of $1.13 to $1.37.
Technical Outlook: Technically, VANI is in a downtrend. Immediate support is located at $1.12, while resistance sits at $1.39.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Implied Volatility is high (100th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $4.83 (+313.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, VANI is in a downtrend. Immediate support is located at $1.12, while resistance sits at $1.39.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Implied Volatility is high (100th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $4.83 (+313.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.13 -
$1.37
Company Quality Score
58/100
(HOLD)
Options IV Signal
100th percentile
(EVENT RISK)
Volume Confirmation
HIGH
Confidence Score
65.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Options expensive (IV 100th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 313.1% below Wall St target ($4.83)
Trading Range Analysis
30-Day Trading Range
$1.13 -
$1.37
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
±$0.42
(35.9%)
Support & Resistance Levels
Support Level
$1.12
Resistance Level
$1.39
Current Trend
Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.08
Wall Street Target
$4.83
(+313.1%)
Share & Embed Analysis
Last updated: May 18, 2026 4:15 AM ET
Data refreshes hourly during market hours. Next update: 5:15 AM
Data refreshes hourly during market hours. Next update: 5:15 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VANI showing a specific setup today?
Insider Activity (6 Months)
5
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Gregg Williams
BUY
1587301 shares
2026-04-15
Gregg Williams
BUY
1575231 shares
2026-03-15
Gregg Williams
BUY
1351351 shares
2026-01-27
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 65 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$875 | 53 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 56 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 55 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 54 HOLD |
